Categoría: Spinal Cord Injury
-
Stem Cells for Spinal Cord Injury
The use of mesenchymal stem cells for a variety have diseases has been published. This includes conditions such as heart failure, liver failure, stroke, and lupus. One of the attractive features of mesenchymal stem cells is that they can differentiate into numerous tissues while at the same time exerting anti-inflammatory activities. In the situation of…
-
Effort to Regenerate Injured Spinal Cords Turns to a New Model
University of Florida McKnight Brain Institute received a $2.4 million National Institutes of Health grant to study regenerative process of the Mexican axolotl salamander with the aim of applying biological lessons learned to spinal cord injury.
-
Geron Could Resume Stem Cell Trial
Geron stated that subsequent to their recent discussions with the FDA, they believe they will have sufficient new animal data to allow for continuation of the trial sometime in thei third quarter of 2010.
-
New Adult Stem Cell Facility Opens in Maryland
The company RNL Biostar has announced the opening of a new adult stem cell R&D facility in Germantown, Maryland.
-
Embryonic Stem Cell Trial Delayed
The Geron Corporation reports a new delay in its clinical trial, which was scheduled to be the first clinical trial ever conducted with human embryonic stem cells.
-
Brain Injuries Targeted for Adult Stem Cell Therapy
Researchers propose adult stem cells derived from adipose tissue as a therapy for traumatic brain injury.
-
NIH Issues Guidelines Restricting Embryonic Stem Cell Research
The U.S. National Institutes of Health have released a draft of guidelines for human embryonic stem cell research, limiting the use of federal funds to research on «spare» embryos that were originally created for reproductive purposes only.
-
Act of Congress Offers Financial Incentive for Cord Blood Banking
New legislation in the U.S. allows for tax benefits in the banking of adult stem cells derived from umbilical cord blood.
-
First Clinical Trial With Human Stem Cells Approved In India
The biotech company Stempeutics has received regulatory authorization to commence the first clinical trial ever to be conducted with human stem cells in India, for the use of adult stem cell therapy in the treatment of two different diseases.
-
Heart Patients Report Dramatic Improvement with Adult Stem Cell Therapy in Clinical Trials
In FDA-approved clinical trials conducted in the U.S. with autologous adult stem cell therapy, heart patients show swift and significant improvement.